Overview

A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Dey
Treatments:
Formoterol Fumarate